GlassScriptPhysician profile
Michael Sheldon Charles
NPI 1942293097
$8,844.65
in general payments reported to CMS, 2019-2025
18 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,244 · 2021: $24.64 · 2022: $220 · 2023: $2,651 · 2024: $4,399 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,001 · Food and Beverage: $2,290 · Education: $65.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,001.31 |
| Food and Beverage | $2,289.50 |
| Education | $65.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $4,128.78 | 2019-2024 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial |
| Abbvie INC. | $2,802.80 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps |
| Kci USA, INC. | $763.90 | 2019 | |
| Allergan, INC. | $437.60 | 2019-2022 | |
| Medtronic, INC. | $166.66 | 2025 | Transorb |
| Astrazeneca Pharmaceuticals LP | $161.87 | 2023-2024 | Andexxa |
| Smith+Nephew, INC. | $108.14 | 2019 | |
| Medline Industries LP | $96.52 | 2019 | |
| Clr Medical, INC. | $75.00 | 2025 | Irrigator |
| Intuitive Surgical, INC. | $64.78 | 2025 | |
| Shire North American Group INC | $22.75 | 2019 | |
| Avanos Medical | $15.85 | 2019 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Charles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.